Causal Relationship Between the Gut Microbiota, Immune Cells, and Coronary Heart Disease: a Mediated Mendelian Randomization Analysis

Overview

Journal Front Microbiol

Specialty Microbiology

Date 2024 Aug 20

PMID 39161605

Authors

Feifei Yang

Hui Song

Weizhi Tang

Lingyun Liu

Ziyi Zhu

Bin Ouyang

Liwen Zhang

Guixin He

Weibin Qin

Affiliations

Soon will be listed here.

Abstract

Background: Recent studies have shown that the gut microbiota (GM), immune cells, and coronary heart disease (CHD) are closely related, but the causal nature of these relationships is largely unknown. This study aimed to investigate this causal relationship and reveal the effect of GM and immune cells on the risk of developing CHD using mediated Mendelian randomization (MR) analysis.

Methods: First, we searched for data related to GM, immune cells, and CHD through published genome-wide association studies (GWAS). We filtered the single nucleotide polymorphisms (SNPs) associated with GM and immune cells and then performed the first MR analysis to identify disease-associated intestinal bacteria and disease-associated immune cells. Subsequently, three MR analyses were conducted: from disease-associated GM to disease-associated immune cells, from disease-associated immune cells to CHD, and from disease-associated GM to CHD. Each MR analysis was conducted using inverse variance weighting (IVW), MR-Egger regression, weighted median, weighted models, and simple models.

Results: A total of six GM and 25 immune cells were found to be associated with CHD. In the MR analysis using the inverse variance weighting (IVW) method, g__Desulfovibrio.s__Desulfovibrio_piger was associated with EM DN (CD4-CD8-) %T cells ( < 0.05 and OR > 1), EM DN (CD4-CD8-) %T cells was associated with CHD ( < 0.05 and OR < 1), and g__Desulfovibrio.s__Desulfovibrio_piger was associated with CHD ( < 0.05 and OR < 1).

Conclusion: An increase in the abundance of g__Desulfovibrio.s__Desulfovibrio_piger leads to an increase in the amount of EM DN (CD4-CD8-) %T cells, and an increase in the amount of EM DN (CD4-CD8-) %T cells reduces the risk of developing CHD. Our study provides some references for reducing the incidence of CHD by regulating GM and immune cells.

References

Wang J, Qie J, Zhu D, Zhang X, Zhang Q, Xu Y . The landscape in the gut microbiome of long-lived families reveals new insights on longevity and aging - relevant neural and immune function. Gut Microbes. 2022; 14(1):2107288. PMC: 9361766. DOI: 10.1080/19490976.2022.2107288. View

Bai H, Gu R, Chen L, Qian Y, Yu M, Xu S . Electroacupuncture interventions alleviates myocardial ischemia reperfusion injury through regulating gut microbiota in rats. Microvasc Res. 2021; 138:104235. DOI: 10.1016/j.mvr.2021.104235. View

Rahman M, Islam F, -Or-Rashid M, Al Mamun A, Rahaman M, Islam M . The Gut Microbiota (Microbiome) in Cardiovascular Disease and Its Therapeutic Regulation. Front Cell Infect Microbiol. 2022; 12:903570. PMC: 9251340. DOI: 10.3389/fcimb.2022.903570. View

Chen W, Zhou D, Torrealba J, Waddell T, Grant D, Zhang L . Donor lymphocyte infusion induces long-term donor-specific cardiac xenograft survival through activation of recipient double-negative regulatory T cells. J Immunol. 2005; 175(5):3409-16. DOI: 10.4049/jimmunol.175.5.3409. View

Simpson R, Shanahan E, Scolyer R, Long G . Towards modulating the gut microbiota to enhance the efficacy of immune-checkpoint inhibitors. Nat Rev Clin Oncol. 2023; 20(10):697-715. DOI: 10.1038/s41571-023-00803-9. View

Zhao N, Wang Y, Ma Y, Liang X, Zhang X, Gao Y . Jia-Wei-Si-Miao-Yong-An decoction modulates intestinal flora and metabolites in acute coronary syndrome model. Front Cardiovasc Med. 2023; 9:1038273. PMC: 9845626. DOI: 10.3389/fcvm.2022.1038273. View

Sun J, Liu S, Ling Z, Wang F, Ling Y, Gong T . Fructooligosaccharides Ameliorating Cognitive Deficits and Neurodegeneration in APP/PS1 Transgenic Mice through Modulating Gut Microbiota. J Agric Food Chem. 2019; 67(10):3006-3017. DOI: 10.1021/acs.jafc.8b07313. View

Chen L, Mou X, Li J, Li M, Ye C, Gao X . Alterations in gut microbiota and host transcriptome of patients with coronary artery disease. BMC Microbiol. 2023; 23(1):320. PMC: 10623719. DOI: 10.1186/s12866-023-03071-w. View

Bowden J, Davey Smith G, Haycock P, Burgess S . Consistent Estimation in Mendelian Randomization with Some Invalid Instruments Using a Weighted Median Estimator. Genet Epidemiol. 2016; 40(4):304-14. PMC: 4849733. DOI: 10.1002/gepi.21965. View

10.

Ahmed R, Gray D . Immunological memory and protective immunity: understanding their relation. Science. 1996; 272(5258):54-60. DOI: 10.1126/science.272.5258.54. View

11.

Chen Y, Jing Q, Chen F, Zheng H, Chen L, Yang Z . is not always associated with adverse health effects in the Guangdong Gut Microbiome Project. PeerJ. 2021; 9:e12033. PMC: 8380029. DOI: 10.7717/peerj.12033. View

12.

Hamad A, Srikrishnan A, Mirmonsef P, Broeren C, June C, Pardoll D . Lack of coreceptor allows survival of chronically stimulated double-negative alpha/beta T cells: implications for autoimmunity. J Exp Med. 2001; 193(10):1113-21. PMC: 2193322. DOI: 10.1084/jem.193.10.1113. View

13.

Xin J, Jiang X, Ben S, Yuan Q, Su L, Zhang Z . Correction: Association between circulating vitamin E and ten common cancers: evidence from large-scale Mendelian randomization analysis and a longitudinal cohort study. BMC Med. 2022; 20(1):281. PMC: 9338564. DOI: 10.1186/s12916-022-02493-z. View

14.

Chatterjee N, Komaravolu R, Durant C, Wu R, McSkimming C, Drago F . Single Cell High Dimensional Analysis of Human Peripheral Blood Mononuclear Cells Reveals Unique Intermediate Monocyte Subsets Associated with Sex Differences in Coronary Artery Disease. Int J Mol Sci. 2024; 25(5). PMC: 10932111. DOI: 10.3390/ijms25052894. View

15.

Xiang M, Wang Y, Gao Z, Wang J, Chen Q, Sun Z . Exploring causal correlations between inflammatory cytokines and systemic lupus erythematosus: A Mendelian randomization. Front Immunol. 2023; 13:985729. PMC: 9893779. DOI: 10.3389/fimmu.2022.985729. View

16.

Burgess S, Thompson S . Interpreting findings from Mendelian randomization using the MR-Egger method. Eur J Epidemiol. 2017; 32(5):377-389. PMC: 5506233. DOI: 10.1007/s10654-017-0255-x. View

17.

Passos L, Koh C, Magalhaes L, Nunes M, Gollob K, Dutra W . Distinct CD4CD8 (Double-Negative) Memory T-Cell Subpopulations Are Associated With Indeterminate and Cardiac Clinical Forms of Chagas Disease. Front Immunol. 2021; 12:761795. PMC: 8632628. DOI: 10.3389/fimmu.2021.761795. View

18.

Chakaroun R, Olsson L, Backhed F . The potential of tailoring the gut microbiome to prevent and treat cardiometabolic disease. Nat Rev Cardiol. 2022; 20(4):217-235. DOI: 10.1038/s41569-022-00771-0. View

19.

Tang W, Hazen S . The Gut Microbiome and Its Role in Cardiovascular Diseases. Circulation. 2017; 135(11):1008-1010. PMC: 5354081. DOI: 10.1161/CIRCULATIONAHA.116.024251. View

20.

Cao L, Ni H, Gong X, Zang Z, Chang H . Chinese Herbal Medicines for Coronary Heart Disease: Clinical Evidence, Pharmacological Mechanisms, and the Interaction with Gut Microbiota. Drugs. 2024; 84(2):179-202. DOI: 10.1007/s40265-024-01994-w. View